SCHEMBL6745364

SCHEMBL6745364

CCCCOC[C@]12CC[C@H]3[C@@H](CC=C4CCCC[C@@]43C)[C@@H]1CCC2=O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 13/20 0.65
CYP1B1 Q16678 1/20 0.51
CYP3A4 P08684 2/20 0.46
EBP Q15125 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
CYP2D6 P10635 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
SHBG P04278 1/20 0.46
SERPINA6 P08185 1/20 0.46
GUSB P08236 1/20 0.46
G6PD P11413 1/20 0.46
PMP22 Q01453 1/20 0.46
KMT2A Q03164 1/20 0.46
GPBAR1 Q8TDU6 1/20 0.46
TSHR P16473 1/20 0.46
GRAMD1A Q96CP6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746497 0.86 CYP19A1 (0.72) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL10605205 0.85 CYP19A1 (0.73) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL1560756 0.85 CYP19A1 (0.77) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL8466445 0.83 CYP19A1 (0.67) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL1428474 0.82 CYP19A1 (0.66) CYP19A1CYP1B1CYP3A4
SCHEMBL29882586 0.82 CYP19A1 (0.65) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL4448095 0.82 CYP19A1 (0.79) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL8532535 0.82 CYP19A1 (0.75) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL4243919 0.82 CYP19A1 (0.75) CYP19A1CYP1B1CYP3A4MEN1LMNA
SCHEMBL8639067 0.82 CYP19A1 (0.75) CYP19A1CYP1B1CYP3A4MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1372664-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES Hollis-Eden Pharmaceuticals Inc. (US) 2004-01-02 EP disclosed
WO-2002069977-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2002-09-12 WO disclosed